Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C-mo Medical Solutions has developed the first and only solution providing a complete, objective, and privacy-protecting assessment of cough. Their wearable device enables long-term, real-time automated analysis of multiple cough traits—frequency, intensity, patterns—delivering actionable insights to clinicians. The product addresses an urgent unmet need in respiratory medicine and is positioned to transform diagnosis, treatment optimization, and patient management in chronic respiratory diseases. As of the latest updates, the company was finalizing regulatory approval with market availability targeted for 2023. No published clinical trial results are available yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C-mo Medical Solutions.